We present an HIV-1-infected patient with a profile of transmitted drug resistance (RT M41L, E44D, V118I, L210W, T215D) sustained during more than 10 years in the absence of treatment. Clonal analysis of different plasma and cellular samples within this period did not reveal any reversion to the wild-type genotype.
Get full access to this article
View all access options for this article.
References
1.
ChaixML, DescampsD, WirdenM, BocketL, DelaugerreC, TamaletCet al.Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France. AIDS, 2009; 23:717–724.
2.
LittleSJ, FrostSD, WongJK, SmithDM, PondSL, IgnacioCCet al.Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol, 2008; 82:5510–5518.
3.
HueS, GiffordRJ, DunnD, FernhillE, PillayD. Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals. J Virol, 2009; 83:2645–2654.
4.
Martinez-PicadoJ, MartinezMA. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo. Virus Res, 2008; 134:104–123.
5.
HarriganPR, BloorS, LarderBA. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J Virol, 1998; 72:3773–3778.
6.
ShaferRW, WintersMA, IversenAK, MeriganTC. Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors. Antimicrob Agents Chemother, 1996; 40:2887–2890.
7.
Salazar-GonzalezJF, SalazarMG, KeeleBF, LearnGH, GiorgiEE, LiHet al.Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med, 2009; 206:1273–1289.
8.
KeeleBF, GiorgiEE, Salazar-GonzalezJF, DeckerJM, PhamKT, SalazarMGet al.Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA, 2008; 105:7552–7557.
